arrow
G

Gregg C. Fonarow

University of California Los Angeles
H指数:198
被引数:19.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Echocardiographic estimates of pulmonary artery acceleration time and mortality risk in older adults

超声心动图评估肺动脉加速时间与老年人死亡风险

2026-10-180
PRE
Longitudinal Changes in Left Ventricular Structure and Function During a Dietary Weight-Management Trial in Adults with Heart Failure, Type 2 Diabetes, and Obesity: A Secondary Analysis of Pro-HEART

心力衰竭、2型糖尿病和肥胖成人膳食体重管理试验期间左心室结构和功能的纵向变化:Pro-HEART研究的一项二次分析

2026-10-010
OA
Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials

Tirzepatide与Dulaglutide在有无动脉粥样硬化性心血管疾病的2型糖尿病中的疗效与安全性:随机临床试验的网络Meta分析

2026-09-290
OAAI
Metabolic and Glycemic Effects of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Diabetes: A Network Meta-Analysis of Randomised Clinical Trials

奥曲格列净(Orforglipron)作为GLP-1受体激动剂,在糖尿病患者及非糖尿病患者中的代谢和血糖效应:一项随机临床试验的网络Meta分析

2026-09-230
OAAI
Racial and Ethnic Differences in Dietary Intake and Metabolic Profiles Among Adults with Heart Failure, Type 2 Diabetes, and Overweight or Obesity: A Secondary Analysis of the Pro-HEART Trial

心衰、2型糖尿病及超重或肥胖成人中种族和族裔在膳食摄入和代谢特征上的差异:Pro-HEART试验的二次分析

2026-08-270
OA
Temporal Trends and Future Projections of P ulmonary Embolism and Top Contributing Causes of death in the United States, 1968-2040: insights from the CDC WONDER database

1968-2040年美国肺栓塞的时序趋势与未来预测及其主要死亡原因:来自CDC WONDER数据库的见解

2026-05-010
PRE
Oral magnesium and outcomes in US veterans with heart failure

口服镁剂及心力衰竭美国退伍军人的结局

2025-12-011
PRE